TherapeuticsmdTXMD
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 44 institutions reported holding Therapeuticsmd Inc. (TXMD) in their 13F filings, down 5 from Q1 2026. 4 opened new positions and 7 sold out. The largest holders were Rubric Capital Management LP ($2.6M), Clearline Capital LP ($1.4M) and Vanguard Capital Management LLC ($782K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Therapeuticsmd Inc.
- CUSIP
- 88338N206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $32K |
| Exits | 7 | $911K |
All 13F filers, Q1 2026 → Q2 2026: 198,840 shares bought and 462,962 shares sold, net −264,122 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 44 holders
| Rubric Capital Management LP | 0.02% | No change | 1,192,191 | $2.6M |
| Clearline Capital LP | 0.09% | No change | 635,222 | $1.4M |
| Vanguard Capital Management LLC | 0.00% | No change | 353,697 | $782K |
| Tejara Capital Ltd | 0.31% | Reduce -0.4% | 344,482 | $761K |
| ADAR1 Capital Management, LLC | 0.04% | Add +63.7% | 342,447 | $757K |
| Renaissance Technologies | 0.00% | Add +0.3% | 146,599 | $324K |
| Morgan Stanley | 0.00% | No change | 129,217 | $286K |
| BlackRock, Inc. | 0.00% | No change | 115,145 | $254K |
| Geode Capital Management, LLC | 0.00% | Reduce -3.6% | 105,849 | $234K |
| Citadel Advisors | 0.00% | Add +26.0% | 86,095 | $190K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 63,831 | $141K |
| State Street Corp. | 0.00% | No change | 30,100 | $67K |
| XTX Topco Ltd | 0.00% | Reduce -22.7% | 21,246 | $47K |
| Dimensional Fund Advisors LP | 0.00% | Add +84.2% | 19,719 | $44K |
| Northern Trust Corp. | 0.00% | Add +15.3% | 18,556 | $41K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 17,000 | $38K |
| Osaic Holdings, Inc. | 0.00% | Add +9833.3% | 15,198 | $34K |
| HRT Financial LP | 0.00% | New | 14,727 | $32K |
| Vanguard Global Advisers, LLC | 0.00% | No change | 4,937 | $11K |
| UBS Group AG | 0.00% | Add +1307.8% | 4,660 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +4.8% | 1,582 | $3K |
| SBI Securities Co., Ltd. | 0.00% | Add +373.0% | 1,263 | $3K |
| Smartleaf Asset Management LLC | 0.00% | No change | 601 | $1K |
| Royal Bank of Canada | 0.00% | Add +338.4% | 833 | $1K |
| Banque Cantonale Vaudoise | 0.00% | No change | 7 | $1K |
| JPMorgan Chase & Co. | 0.00% | No change | 293 | $657 |
| US Bancorp \de | 0.00% | No change | 246 | $544 |
| BNP Paribas Financial Markets | 0.00% | Reduce -0.9% | 224 | $495 |
| Huntington National Bank | 0.00% | No change | 120 | $265 |
| Wells Fargo & Company | 0.00% | No change | 115 | $254 |
| Citigroup Inc. | 0.00% | New | 64 | $141 |
| Activest Wealth Management | 0.00% | No change | 40 | $88 |
| Atlatl Advisers LLC | 0.00% | New | 40 | $88 |
| Farther Finance Advisors, LLC | 0.00% | Add +25.8% | 39 | $86 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 35 | $77 |
| Barclays PLC | 0.00% | New | 22 | $49 |
| IFP Advisors, Inc | 0.00% | No change | 21 | $46 |
| Provenance Wealth Advisors, LLC | 0.00% | No change | 20 | $44 |
| Truvestments Capital LLC | 0.00% | No change | 10 | $22 |
| Harbour Investments, Inc. | 0.00% | No change | 8 | $18 |
| Bogart Wealth, LLC | 0.00% | No change | 2 | $4 |
| Smallwood Wealth Investment Management, LLC | 0.00% | No change | 2 | $4 |
| Johnson Financial Group, Inc. | 0.00% | No change | 1 | $3 |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is TXMD's weight in each manager's 13F, not the share of Therapeuticsmd Inc. the manager owns.